Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, Beishuizen A, Cepelova M, Ceppi F, Fernandez-Teijeiro A, Fosså A, Georgi TW, Hjalgrim LL, Hraskova A, Leblanc T, Mascarin M, Pears J, Landman-Parker J, Prelog T, Klapper W, Ramsay A, Kluge R, Dieckmann K, Pelz T, Vordermark Det al.(2025) Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial JAMA Oncol, 11(3), 258-267 DOI 10.1001/jamaoncol.2024.5636, PubMed 39745682
Flølo TN, Tørris C, Riiser K, Almendingen K, Chew HSJ, Fosså A, Albertini Früh E, Hennessy E, Leung MM, Misvær N, Pavel N, Sundar TKB, Sæterstrand TM, Torbjørnsen A, Løyland B, Holmen H(2025) Digital health interventions to treat overweight and obesity in children and adolescents: An umbrella review Obes Rev, e13905(in press) DOI 10.1111/obr.13905, PubMed 39972996
Forsgren E, Jørgensen RRK, Bentzen H, Riise J, Haaber J, Pasanen A, Kuitunen H, Wader KF, El-Galaly TC, Hutchings M, Glimelius I, Jerkeman M(2025) Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial Hemasphere, 9(3), e70101 DOI 10.1002/hem3.70101, PubMed 40104044
